3D-printed wound scaffolds deliver plant-based antimicrobials to chronic wounds

Chronic wounds are a slow-motion crisis. Diabetic ulcers, pressure sores, and other persistent wounds affect millions of people, often lingering for months or years because reduced blood flow and oxygen supply undermine the body's repair mechanisms. Infection compounds the problem, and the standard tools for fighting it - conventional antibiotics applied over extended periods - risk breeding resistant bacteria.

A team at the University of Mississippi's School of Pharmacy thinks the answer might come from a 3D printer.

Printing a patch that fits any wound

Michael Repka, Sateesh Vemula, and Nouf Alshammari have developed a 3D-printed wound scaffold - a breathable, patch-like structure that can be placed directly over a wound. The scaffold is built from chitosan, a natural material derived from the shells of crustaceans, insects, and fungi, combined with plant-derived antimicrobial compounds. Their results were published in the European Journal of Pharmaceutics and Biopharmaceutics.

The manufacturing approach offers a key advantage: because each scaffold is 3D-printed, it can be tailored to fit any wound on any part of the body. A diabetic foot ulcer and a pressure sore on the lower back have very different geometries, and a one-size bandage does not address either optimally.

Why not just use a regular bandage?

For simple cuts and scrapes, a regular bandage works fine. But chronic wounds present a different challenge. They need sustained antimicrobial protection, a structural scaffold to encourage cell growth, and materials that will not introduce additional chemical irritants into an already compromised wound bed.

Many existing medicated bandages use organic solvents during manufacturing. Those solvents can harm the wound-healing process, especially when the bandage is applied directly to open tissue. The chitosan-based scaffold avoids this entirely - no organic solvents are involved in its production.

The choice of plant-derived antimicrobials over traditional antibiotics addresses another chronic wound challenge: resistance. When conventional antibiotics are applied over the weeks or months that chronic wounds require, bacteria can develop resistance. Natural antimicrobial compounds do not carry the same risk profile.

Biodegradable by design

The scaffold is not just a delivery vehicle for antimicrobials. It is designed to be absorbed into the skin over time. The chitosan base accelerates skin cell growth while reducing inflammation and preventing infection. As the wound heals, the scaffold degrades - no removal necessary.

That biodegradability has implications beyond surface wounds. For internal applications, a scaffold that dissolves on its own eliminates the need for a second surgical procedure to remove it. The materials involved are biologically inactive, meaning the research team expects no side effects or toxic residuals from the degradation process.

Field applications and military potential

The researchers see potential far beyond hospital settings. A 3D printer running on a portable generator could produce customized wound scaffolds in the field - in military settings, remote clinics, or disaster zones where access to specialized wound care is limited.

The ability to print a scaffold tailored to the specific wound type and location, loaded with appropriate antimicrobials, on demand and on site, represents a different model of wound care than shipping pre-manufactured bandages.

The road to patients

The technology is still in the research phase. Before it can be used clinically, the scaffold will need further testing and review by the Food and Drug Administration. The current publication demonstrates feasibility and the properties of the materials, but clinical trials in human patients have not yet begun.

The timeline from published research to FDA-cleared medical device is typically measured in years, not months. But the underlying materials - chitosan and plant-derived compounds - have established safety profiles that may simplify the regulatory path compared to novel synthetic materials.